CRANDELL KEITH sold $40K of BOLD (indirect holdings)
CRANDELL KEITH sold 16,000 indirectly-held shares of Boundless Bio, Inc. (BOLD) at $2.49 on 2026-07-01.
How this was made
The 30-second read
Why it matters
The newest fact is the sale details (16,000 shares at $2.49; holdings after transaction: 0 shares) without any accompanying company-specific news.
Market read
Traders may monitor for follow-on insider activity, but this filing alone does not change fundamentals.
What to watch
The filing notes an indirect holding and that no 10b5-1 plan was used, but it does not explain the reason for sale or any concurrent company developments.
Background
The article is a SEC Form 4 insider transaction disclosure for Boundless Bio, Inc.
Ticker impact
Boundless Bio’s 10% owner CRANDELL KEITH sold 16,000 shares in an open-market transaction at $2.49 on 2026-07-01.
Likely limited near-term impact; any effect should be small and sentiment-driven.
The filing discloses transaction size, price, and post-sale holdings (0 shares) but provides no operational, financial, or regulatory catalyst.
Market effects
No clear sector read-through; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
Insider sales can be non-informational (tax/liquidity) and the disclosed price/size may not signal a change in outlook.
Key entities
- issuerBoundless Bio, Inc.
Subject of the Form 4 insider sale disclosure.
- insiderCRANDELL KEITH
10% owner who sold 16,000 shares in an open-market transaction.